168 related articles for article (PubMed ID: 38559593)
21. Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.
Lin Z; Li Q; Sun Y; Huang J; Wang W; Fu J; Xu J; Zeng D
Lipids Health Dis; 2019 Jun; 18(1):143. PubMed ID: 31200713
[TBL] [Abstract][Full Text] [Related]
22. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN
Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
[TBL] [Abstract][Full Text] [Related]
23. MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort.
Nursal AF; Kaya S; Sezer O; Karakus N; Yigit S
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28543752
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.
Lopez-Lopez E; Martin-Guerrero I; Ballesteros J; Garcia-Orad A
Pharmacogenomics J; 2013 Dec; 13(6):498-506. PubMed ID: 23089671
[TBL] [Abstract][Full Text] [Related]
25. More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate.
Xie L; Guo W; Yang Y; Ji T; Xu J
Oncotarget; 2018 Feb; 9(14):11465-11476. PubMed ID: 29545912
[TBL] [Abstract][Full Text] [Related]
26. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
Saleh MM; Irshaid YM; Mustafa KN
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
Zgheib NK; Akra-Ismail M; Aridi C; Mahfouz R; Abboud MR; Solh H; Muwakkit SA
Pharmacogenet Genomics; 2014 Aug; 24(8):387-96. PubMed ID: 25007187
[TBL] [Abstract][Full Text] [Related]
28. MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.
Umerez M; Gutierrez-Camino Á; Muñoz-Maldonado C; Martin-Guerrero I; Garcia-Orad A
Pharmgenomics Pers Med; 2017; 10():69-78. PubMed ID: 28392709
[TBL] [Abstract][Full Text] [Related]
29. MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy.
Frikha R; Elloumi M; Rebai T; Kamoun H
J Oncol Pharm Pract; 2022 Jul; 28(5):1031-1034. PubMed ID: 34000920
[TBL] [Abstract][Full Text] [Related]
30. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
[TBL] [Abstract][Full Text] [Related]
31. Association of MTHFR C677T and A1298C gene polymorphisms with methotrexate efficiency and toxicity in Algerian rheumatoid arthritis patients.
Berkani LM; Rahal F; Allam I; Mouaki Benani S; Laadjouz A; Djidjik R
Heliyon; 2017 Nov; 3(11):e00467. PubMed ID: 29264421
[TBL] [Abstract][Full Text] [Related]
32. Influence of Methylenetetrahydrofolate Reductase C677T, A1298C, and G80A Polymorphisms on the Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
de Deus DM; de Lima EL; Seabra Silva RM; Leite EP; Cartaxo Muniz MT
Leuk Res Treatment; 2012; 2012():292043. PubMed ID: 23198157
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S
Front Pediatr; 2020; 8():307. PubMed ID: 32612964
[No Abstract] [Full Text] [Related]
34. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
Zheng MM; Yue LJ; Chen XW; Wen FQ; Li CG; Yang CL; Xie C; Ding H
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
[TBL] [Abstract][Full Text] [Related]
35. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
Lee YH; Song GG
Clin Drug Investig; 2010; 30(2):101-8. PubMed ID: 20067328
[TBL] [Abstract][Full Text] [Related]
36. Association between maternal
Lu YJ; Li Q; Chen LX; Tian T; Kang J; Hao YX; Zhou JS; Wang YY; Yan LY; Li R; Chang L; Qiao J
Hum Reprod Open; 2023; 2023(1):hoac055. PubMed ID: 36531663
[TBL] [Abstract][Full Text] [Related]
37. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
38. Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
Chang X; Guo Y; Su L; Zhang Y; Hui W; Zhao H; Hu R; Sun W
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):91-96. PubMed ID: 33069634
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia.
Esmaili MA; Kazemi A; Faranoush M; Mellstedt H; Zaker F; Safa M; Mehrvar N; Rezvany MR
Iran J Basic Med Sci; 2020 Jun; 23(6):800-809. PubMed ID: 32695297
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism in
Zhang YX; Ma Y; Zhang H; Zhang WP; Yang XY
Int J Clin Pharmacol Ther; 2020 May; 58(5):254-260. PubMed ID: 32053102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
